Influence of berberine on T-cell mediated immunity

Immunopharmacology and Immunotoxicology

Volumn 21, Issue 4, 1999, Pages 771-786

  Ivanovska, N ^a   Philipov, S ^b   Hristova, M ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CONCANAVALIN A; PHYTOHEMAGGLUTININ;

ADJUVANT ARTHRITIS; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DOSE RESPONSE; DRUG STRUCTURE; FEMALE; INFECTION RESISTANCE; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NEWBORN; NONHUMAN; PAW EDEMA; PLANT ROOT; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ANIMALIA; BERBERIS VULGARIS; CANDIDA ALBICANS;

EID: 0032726473     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979909007141     Document Type: Article

References (21)

1. Khin-Maung, U. and Myo, K., Nyunt-Nyunt, W. and Tin, U., Chemical trial of high-dose berberine and tetracycline in cholera, J. Diarrhoeal Dis. Res., 5: 184, 1987.
2. Marin-Neto, J. A., Maciel, B. C., Secches, A. L. and Gallo Junior, L., Cardiovascular effects of berberine in patients with severe congestive heart failure, Clinical Cardiology, 11:253, 1988.
3. Huang, W., Ventricular tachycardias treated with berberine, Chin. J. Cardiovasc. Dis., 18: 155, 1990.
4. Hua, Z. and Wang, X. L., Inhibitory effects of berberine on potassium channels in guinea pig ventricular myocytes, Acta Pharm. Sinica, 9: 576, 1994.
5. + channels in cardiac myocytes, Eur. J. Pharmacol., 316: 307, 1996.
6. Taylor, C. T. and Baird, A. W., Berberine inhibits electrogenic chloride secretion in rat colon in vitro, Br. J. Pharmacol., 110: 129, 1993.
7. Taylor, C. T. and Baird, A. W., Berberine inhibition of electrogenic ion transport in rat colon, Br. J. Pharmacol., 116: 2667, 1995.
8. Niwa, M., Mibu, H., Nozaki, M., Tsurumi, K. and Fujimura, H., Dopaminergic unique affinity of tetrahydroberberine-d-camphor sulfonate, Pharmacology, 43: 329, 1991.
9. Olmez, E. and Ilhan, M., Evaluation of the alpha-adrenoceptor antagonistic action of berberine in isolated organs, Arzneimittel-Forschung, 42: 1095, 1992.
10. Whiteley,. C. G. and Daya, S., Protein-ligand interactions. 6 Nicotinic acetylcholine receptor agonist activity of isoquinoline alkaloids, Bioorganic Med. Chem. Lett., 23: 2801, 1996.
11. Ivanovska, N. and Philipov, S., Modulation of mice host resistance in Klebsiella pneumoniae infection by the alkaloid berberine, Pharm. Pharmacol. Lett., 5: 139, 1995.
12. Ivanovska, N. and Philipov, S., Study on the antiinflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids, Int. J. Immunopharmac., 10: 553, 1996.
13. Ivanovska, N., Philipov, S. and Nikolova, P., Effect of berberine and its combination with immunosuppressive drugs in adjuvant arthritis and DTH reaction in mice, Pharm. Pharmacol. Lett., 2/3: 55, 1997.
14. Fierestein, G. S. and Zvifler, N. J., How important are T cells in chronic rheumatoid synovitis?, Arthritis Rheum., 33: 768, 1990.
15. T'Hart, A. B. and Otten, H. G., Prospects of immunotherapy of rheumatoid arthritis, Pharm. World Sci., 17: 178, 1995.
16. Kagaya, K. T., Shinoda, T. and Fukazawa, Y., Murine defense mechanism against Candida albicans infection. I. Collaboration of cell-mediated and humoral immunities in protection against systemic C. albicans infection, Microbiol. Immunol., 25: 647, 1981.
17. Ashman, R. B., Murine candidiasis: cell mediated immune responses correlate directly with suspectibility and resistance to infection, Cell Biol., 68: 179, 1990.
18. Ashman, R. B. and Papadimitriou, M. J., Production and function of cytokines in natural and acquired immunity to Candida albicans infection, Microbiol. Rev., 59: 646, 1995.
19. Rabbani, G. H., Butler, T., Knight, J., Sanyal, S. C. and Alam, K., Randomized controlled trial of berberine sulfate therapy for diarrhoea due to enterotoxigenic Escherichia coli and Vibrio cholerae, J. Infect. Dis., 155: 879, 1987.
20. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immun. Meth., 65: 55, 1983.
21. Mencacci, A., Cenci, E., Bistoni, F., Bacci, A., Del Sero, G., Montagnoli, C., Fè d'Ostiani, C. and Romani, L. Specific and non-specific immunity to Candida albicans: a lesson from genetically modified animals, Res Immunol., 149: 352, 1998.